| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,759 |
1,350 |
$719K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,161 |
955 |
$297K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
282 |
169 |
$112K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
26 |
$18.75 |
| 96160 |
|
267 |
238 |
$6.56 |
| 84520 |
|
265 |
213 |
$0.00 |
| 82947 |
|
267 |
214 |
$0.00 |
| 82565 |
|
268 |
214 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
28 |
24 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
32 |
29 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
492 |
382 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
77 |
51 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
281 |
201 |
$0.00 |
| 80051 |
|
268 |
214 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14 |
12 |
$0.00 |
| 96161 |
|
17 |
15 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
14 |
$0.00 |
| 81001 |
|
12 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
40 |
21 |
$0.00 |